Cargando…
Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. Antibody resistance dampens neutralizing antibody therapy and threatens current global Coronavirus (COVID-19) vaccine campaigns. In addition to the emergence of resistant SARS-CoV-2 variants, little is known a...
Autores principales: | Xia, Bingqing, Pan, Xiaoyan, Luo, Rong-Hua, Shen, Xurui, Li, Shuangqu, Wang, Yi, Zuo, Xiaoli, Wu, Yan, Guo, Yingqi, Xiao, Gengfu, Li, Qiguang, Long, Xin-Yan, He, Xiao-Yan, Zheng, Hong-Yi, Lu, Ying, Pang, Wei, Zheng, Yong-Tang, Li, Jia, Zhang, Lei-Ke, Gao, Zhaobing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821354/ https://www.ncbi.nlm.nih.gov/pubmed/36609376 http://dx.doi.org/10.1038/s41421-022-00510-2 |
Ejemplares similares
-
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
por: Xia, Bingqing, et al.
Publicado: (2021) -
Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB
por: Wang, Yi, et al.
Publicado: (2023) -
Enhanced channel activity by PI(4,5)P(2) ignites MLKL-related pathogenic processes
por: Xia, Bingqing, et al.
Publicado: (2022) -
Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022) -
Mesenchymal Stem Cell-Derived Extracellular Vesicles in Liver Immunity and Therapy
por: Wu, Ruiqi, et al.
Publicado: (2022)